CIK: 0001615982 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $1,909,252 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 8,493,321 | $498,898 | 26.1% | $22.03 | +117.5% | COM | 03770N101 |
| OCUL | OCULAR THERAPEUTIX INC | 12,762,462 | $111,033 | 5.8% | $4.57 | +80.2% | COM | 67576A100 |
| ELVN | ENLIVEN THERAPEUTICS INC | 4,026,331 | $102,832 | 5.4% | $18.38 | +26.0% | COM | 29337E102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,882,709 | $88,332 | 4.6% | $19.32 | -15.4% | COM | 92790C104 |
| — | APPLIED THERAPEUTICS INC | 9,825,000 | $83,513 | 4.4% | $3.36 | — | COM | 03828A101 |
| SYRE | SPYRE THERAPEUTICS INC | 2,685,448 | $78,979 | 4.1% | $17.59 | +58.3% | COM NEW | 00773J202 |
| DYN | DYNE THERAPEUTICS INC | 2,173,913 | $78,087 | 4.1% | $11.80 | +237.4% | COM | 26818M108 |
| ORKA | ORUKA THERAPEUTICS INC | 3,085,620 | $75,629 | 4.0% | $34.79 | 0.0% | COM | 687604108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 6,249,731 | $72,372 | 3.8% | $8.81 | +42.7% | COM | 483497103 |
| PHVS | PHARVARIS N V | 3,395,606 | $62,887 | 3.3% | $15.96 | +14.5% | COM | N69605108 |
| COGT | COGENT BIOSCIENCES INC | 5,684,167 | $61,389 | 3.2% | $8.47 | +15.0% | COM | 19240Q201 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,744,373 | $47,761 | 2.5% | $17.70 | +57.4% | COM | 252828108 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,400,000 | $47,564 | 2.5% | $19.48 | -14.8% | COM | 35104E100 |
| — | MERUS N V | 907,963 | $45,362 | 2.4% | $20.36 | — | COM | N5749R100 |
| ORIC | ORIC PHARMACEUTICALS INC | 4,394,527 | $45,044 | 2.4% | $8.55 | +15.6% | COM | 68622P109 |
| ERAS | ERASCA INC | 16,216,216 | $44,270 | 2.3% | $2.16 | +30.5% | COM | 29479A108 |
| PRAX | PRAXIS PRECISION MEDICINES I | 706,131 | $40,631 | 2.1% | $31.41 | +72.0% | COM NEW | 74006W207 |
| — | ASTRIA THERAPEUTICS INC | 3,458,645 | $38,080 | 2.0% | $8.36 | — | COM | 04635X102 |
| TERN | TERNS PHARMACEUTICALS INC | 3,410,058 | $28,440 | 1.5% | $4.28 | +92.4% | COM | 880881107 |
| AQST | AQUESTIVE THERAPEUTICS INC | 5,555,555 | $27,667 | 1.4% | $3.33 | +16.9% | COM | 03843E104 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,000,000 | $26,690 | 1.4% | $15.89 | +25.2% | COM | 28036F105 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 1,609,569 | $24,868 | 1.3% | $11.59 | 0.0% | COM | 04317A107 |
| ENGN | ENGENE HOLDINGS INC | 3,565,841 | $23,535 | 1.2% | $11.28 | -34.1% | COM | 29286M105 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,379,965 | $23,101 | 1.2% | $21.29 | -16.7% | COM | 230031106 |
| — | MERSANA THERAPEUTICS INC | 11,328,000 | $21,410 | 1.1% | $1.27 | — | COM | 59045L106 |
| TSHA | TAYSHA GENE THERAPIES INC | 9,000,000 | $18,090 | 0.9% | $1.87 | +17.5% | COM SHS | 877619106 |
| ABVX | ABIVAX SA | 1,345,780 | $15,503 | 0.8% | $11.63 | — | SPONSORED ADS | 00370M103 |
| TRVI | TREVI THERAPEUTICS INC | 3,422,656 | $11,432 | 0.6% | $2.46 | +20.7% | COM | 89532M101 |
| ARVN | ARVINAS INC | 454,450 | $11,193 | 0.6% | $23.38 | +11.7% | COM | 04335A105 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,467,048 | $10,299 | 0.5% | $14.14 | — | COM NEW | 00773U207 |
| IPSC | CENTURY THERAPEUTICS INC | 5,389,259 | $9,216 | 0.5% | $3.84 | -49.0% | COM | 15673T100 |
| ZURA | ZURA BIO LTD | 2,023,166 | $8,214 | 0.4% | $4.08 | -8.4% | CLASS A ORD SHS | G9TY5A101 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7,515 | 0.4% | $10.07 | -0.1% | CL A ORD SHS | G70077105 |
| CABA | CABALETTA BIO INC | 1,563,952 | $7,382 | 0.4% | $6.85 | -15.5% | COM | 12674W109 |
| CASIF | CASI PHARMACEUTICALS INC | 987,259 | $6,082 | 0.3% | $6.09 | +6.2% | ORD SHS | G1933S101 |
| TNYA | TENAYA THERAPEUTICS INC | 1,555,556 | $3,002 | 0.2% | $4.78 | -41.0% | COM | 87990A106 |
| TIL | INSTIL BIO INC | 33,177 | $2,233 | 0.1% | $23.54 | 0.0% | COM NEW | 45783C200 |
| TENX | TENAX THERAPEUTICS INC | 208,333 | $721 | 0.0% | $3.62 | 0.0% | COM NEW | 88032L605 |